Les Cleland

597 total citations
20 papers, 433 citations indexed

About

Les Cleland is a scholar working on Rheumatology, Pathology and Forensic Medicine and Nutrition and Dietetics. According to data from OpenAlex, Les Cleland has authored 20 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 5 papers in Pathology and Forensic Medicine and 4 papers in Nutrition and Dietetics. Recurrent topics in Les Cleland's work include Rheumatoid Arthritis Research and Therapies (5 papers), Fatty Acid Research and Health (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Les Cleland is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Fatty Acid Research and Health (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Les Cleland collaborates with scholars based in Australia, United Kingdom and Norway. Les Cleland's co-authors include Michael J. James, Susanna Proudman, Erling N. Christiansen, Artemis P. Simopoulos, J. R. Jonsson, D. B. Frewin, Llewellyn Spargo, Michael Ahern, Joanna S. Hawkes and Michael Coleman and has published in prestigious journals such as The Journal of Immunology, Journal of Nutrition and Lara D. Veeken.

In The Last Decade

Les Cleland

20 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Les Cleland Australia 11 127 117 102 76 65 20 433
AK Black Thailand 9 96 0.8× 165 1.4× 64 0.6× 40 0.5× 76 1.2× 14 558
Catriona Sharp United Kingdom 6 113 0.9× 62 0.5× 64 0.6× 17 0.2× 79 1.2× 7 357
José Luis Gálvez-Romero Mexico 9 91 0.7× 134 1.1× 18 0.2× 42 0.6× 59 0.9× 25 326
L. Liu China 10 97 0.8× 32 0.3× 38 0.4× 63 0.8× 201 3.1× 20 470
Gady G Katz Canada 13 63 0.5× 56 0.5× 16 0.2× 114 1.5× 107 1.6× 19 622
H Louis Belgium 11 151 1.2× 36 0.3× 19 0.2× 59 0.8× 99 1.5× 25 706
Tsutomu Hibino Japan 12 68 0.5× 17 0.1× 37 0.4× 55 0.7× 167 2.6× 21 515
Maha E. Houssen Egypt 13 102 0.8× 76 0.6× 19 0.2× 46 0.6× 130 2.0× 27 455
H Moriwaki Japan 10 58 0.5× 18 0.2× 47 0.5× 40 0.5× 187 2.9× 22 664
Guanqun Xie China 12 89 0.7× 63 0.5× 15 0.1× 31 0.4× 130 2.0× 27 356

Countries citing papers authored by Les Cleland

Since Specialization
Citations

This map shows the geographic impact of Les Cleland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Les Cleland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Les Cleland more than expected).

Fields of papers citing papers by Les Cleland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Les Cleland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Les Cleland. The network helps show where Les Cleland may publish in the future.

Co-authorship network of co-authors of Les Cleland

This figure shows the co-authorship network connecting the top 25 collaborators of Les Cleland. A scholar is included among the top collaborators of Les Cleland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Les Cleland. Les Cleland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reid, Alistair, Michael D. Wiese, Cindy Hall, et al.. (2020). Repeat serological testing for anti‐citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis. Internal Medicine Journal. 50(7). 818–822. 3 indexed citations
2.
Brown, Zoe, Robert G. Metcalf, Jana Bednarz, et al.. (2020). Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis. ACR Open Rheumatology. 2(6). 371–377. 8 indexed citations
3.
Hill, Catherine, Graeme Jones, Steven J. Lester, et al.. (2013). Effect of fish oil on structural progression in knee osteoarthritis: a two year randomized, double-blind clinical trial comparing high dose with low dose. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations
4.
Rozek, Tomas, Ashley M. Hopkins, Susanna Proudman, et al.. (2011). Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 55(2). 325–331. 41 indexed citations
5.
James, Michael J., Susanna Proudman, & Les Cleland. (2010). Fish oil and rheumatoid arthritis: past, present and future. Proceedings of The Nutrition Society. 69(3). 316–323. 65 indexed citations
6.
Whittle, Samuel, et al.. (2008). Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy. Clinical Rheumatology. 27(12). 1593–1595. 3 indexed citations
7.
Philpott, Hamish, Pravin Hissaria, Nimit Singhal, et al.. (2008). Eosinophilic fasciitis as a paraneoplastic phenomenon associated with metastatic colorectal carcinoma. Australasian Journal of Dermatology. 49(1). 27–29. 13 indexed citations
8.
Cleland, Les, et al.. (2008). A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica. Clinical Rheumatology. 27(S2). 67–69. 7 indexed citations
9.
Lester, Sue, et al.. (2008). Treatment‐induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis. Internal Medicine Journal. 39(5). 296–303. 12 indexed citations
10.
Cleland, Les, Michael J. James, Helen Keen, et al.. (2005). Fish oil - an example of an anti-inflammatory food. Asia Pacific Journal of Clinical Nutrition. 14. 66–71. 7 indexed citations
11.
Simopoulos, Artemis P., Les Cleland, & Erling N. Christiansen. (2004). Omega-6/omega-3 essential fatty acid ratio: the scientific evidence. 48(1). 49–50. 76 indexed citations
12.
Walker, Jenny, Michael Ahern, Malcolm Smith, et al.. (2003). Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Internal Medicine Journal. 33(5-6). 216–220. 55 indexed citations
13.
Spargo, Llewellyn, et al.. (2001). Characterization of thoracic duct cells that transfer polyarthritis. Clinical & Experimental Immunology. 126(3). 560–569. 12 indexed citations
14.
James, Michael J., David van Reyk, Kerry‐Anne Rye, et al.. (1998). Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized. Lipids. 33(11). 1115–1121. 24 indexed citations
15.
Cleland, Les, Robert A. Gibson, Mark A. Neumann, et al.. (1996). Dietary (n-9) Eicosatrienoic Acid from a Cultured Fungus Inhibits Leukotriene B4 Synthesis in Rats and the Effect Is Modified by Dietary Linoleic Acid. Journal of Nutrition. 126(6). 1534–1540. 19 indexed citations
16.
Spargo, Llewellyn, Joanna S. Hawkes, Les Cleland, & Graham Mayrhofer. (1996). Recruitment of lymphoblasts derived from peripheral and intestinal lymph to synovium and other tissues in normal rats and rats with adjuvant arthritis. The Journal of Immunology. 157(11). 5198–5207. 19 indexed citations
17.
Bochner, Felix, Gerard J. Graham, Anthony Polverino, et al.. (1987). Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis. European Journal of Clinical Pharmacology. 32(2). 153–158. 10 indexed citations
18.
Frewin, D. B., et al.. (1986). Histamine levels in human synovial fluid.. PubMed. 13(1). 13–4. 55 indexed citations
19.
Norman, John, et al.. (1983). DERMAL NECROSIS AND CHROMOSOME Iq ABNORMALITY IN A MAN WITH A FAMILIAL MYELOPROLIFERATIVE DISORDER. Australian and New Zealand Journal of Medicine. 13(2). 141–145. 1 indexed citations
20.
Brooks, Peter, et al.. (1982). EVALUATION OF A SINGLE DAILY DOSE NAPROXEN IN OSTEOARTHRITIS. Lara D. Veeken. 21(4). 242–246. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026